HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.

Abstract
On behalf of the Nova Scotia Seniors' Pharmacare Program, the Drug Evaluation Alliance of Nova Scotia developed a multicomponent intervention plan to facilitate the removal of chlorpropamide as an insured benefit. Chlorpropamide has caused serious hypoglycemia in seniors to a greater extent than some other agents. Pharmacy administrative claims were used to compute monthly use rates for insulin and each oral antihyperglycemic drug from January 1, 2000-December 30, 2002, in an intervention cohort (patients receiving chlorpropamide) and a control cohort (patients receiving an antihyperglycemic agent other than chlorpropamide). Initially, 630 patients were receiving chlorpropamide therapy. By the time chlorpropamide was deinsured, only 10% of the treatment cohort continued receiving chlorpropamide; shortly after deinsurance, no beneficiaries continued receiving the drug. The antihyperglycemics with the greatest increase in prescription were glyburide and gliclazide. The deinsuring of chlorpropamide and the educational strategies that accompanied it resulted in the selection of more appropriate antihyperglycemics for Nova Scotia seniors.
AuthorsIngrid S Sketris, George C Kephart, Dawn M Frail, Chris Skedgel, Michael J Allen
JournalPharmacotherapy (Pharmacotherapy) Vol. 24 Issue 6 Pg. 784-91 (Jun 2004) ISSN: 0277-0008 [Print] United States
PMID15222669 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypoglycemic Agents
  • Chlorpropamide
Topics
  • Aged
  • Chlorpropamide (adverse effects, economics, therapeutic use)
  • Cohort Studies
  • Drug Utilization Review
  • Education, Medical, Continuing
  • Formularies as Topic
  • Government Programs
  • Humans
  • Hypoglycemia (chemically induced)
  • Hypoglycemic Agents (adverse effects, economics, therapeutic use)
  • Insurance, Pharmaceutical Services
  • Nova Scotia
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: